Health Care/Hospital

WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu

CHENGDU, China, May 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that the construction of a new 1.3 million sq. ft....

2019-05-16 15:39 3831

Merck Data at ASCO 2019 Showcase Multiple Innovative Molecules with Potential to Impact Unmet Needs in Cancer Care

DARMSTADT, Germany, May 16 2019 /PRNewswire/ --    Not intended for UK- , Canada- or US-based media ASCO Abstract # Bintrafusp alfa (bifunctional fusion protein): TPS9114; Tepotinib (MET kinase inhibitor): 9005; Discovery: 2567; ERBITUX® (cetuximab): 3580; BAVENCIO® (avelumab): 9569; 10...

2019-05-16 15:36 2118

Innovent Will Provide Key Results Update of Several Clinical Studies at 2019 ASCO Annual Meeting

SUZHOU, China, May 16, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...

2019-05-16 08:00 7965

Datatrak International, Inc. CEO to speak at 2019 DIA China Annual Meeting

CLEVELAND, May 16, 2019 /PRNewswire/ -- Datatrak International, Inc. (OTC Markets: DTRK), a worldwide Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry, today announced that CEOJim Bob Ward will be speaking at the 2019 China DIA...

2019-05-16 07:59 3146

Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results

WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...

2019-05-16 05:00 11006

Anpac Bio Gains U.S. CLIA Lab Certification

SACRAMENTO, California, May 16, 2019 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation,Anpac Bio-Medical Science Company (Anpac Bio), announced today that the company's United States subsidiary, Anpac TechnologyUSA, successfully passed the State of C...

2019-05-16 04:16 2294

Natural Alternatives International Announces Participation as Exhibitor and Presenter In the 2019 ifia® Japan

CARLSBAD, California, May 16, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) today announced its participation, partnering with NAI's exclusive distributor, Shimizu Chemical Corporation, in the 24th edition of the ifia® Japan, The International Food Ingredien...

2019-05-16 00:53 5635

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

CHENNAI, India, May 15, 2019 /PRNewswire/ -- In a first-ever milestone in cancer treatment inIndia, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant.  

2019-05-15 22:46 2367

Inovio and Plumbline Life Sciences Establish Animal Health Collaboration to Develop A Novel Vaccine Against Deadly African Swine Fever Virus

PLYMOUTH MEETING, Pennsylvania and SEOUL, South Korea, May 15, 2019 /PRNewswire/ -- Inovio Pharmaceuticals Inc. (NASDAQ: INO) and Plumbline Life Sciences (XKRX: 222670) today announced a collaboration to co-develop a novel animal health vaccine for African swine fever (ASF) virus. The vaccine...

2019-05-15 21:00 2822

Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1

HANGZHOU, China, May 15, 2019 /PRNewswire/ -- Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of1.5 billion yuan, according to the latest data of the Hangzhou Investment Promotion...

2019-05-15 20:56 3141

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...

2019-05-15 20:13 1887

Connell broadens offering to its Life Science customers with the acquisition of Ingredient Resources

SAN FRANCISCO, May 15, 2019 /PRNewswire/ -- Connell, a Wilbur-Ellis company and a leading marketer and distributor of specialty chemicals and ingredients in Asia-Pacific, announces today the acquisition of Ingredient Resources Pty Limited, a supplier and distributor of innovative, valued-added ing...

2019-05-15 19:00 2759

China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results

HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2019-05-15 18:00 8352

Ping An completes multi-center clinical trials for world's first intelligent OCT retinal disease screening system

SHANGHAI and HONG KONG, May 15, 2019 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("China Ping An", "Ping An", the "Group" or the "Company"; stock codes: HKEX 2318 and SSE 601318) is pleased to announce that its technology arm, Ping An Technology, has completed a prospective ...

2019-05-15 17:51 9220

Hong Kong Science Park Leads Start-Up Delegation to North America's Fastest Growing Technology Conference in Toronto

HONG KONG, May 15, 2019 /PRNewswire/ -- Hong Kong Science and Technology Parks Corporation ("HKSTP") today announced that it is leading a delegation of 14 start-ups to Collision, one ofNorth America's leading technology conference, to be held inToronto, Canada from May 20 - 23, 2019. Leveraging o...

2019-05-15 16:02 2162

Ping An Good Doctor and Wyeth Reached Strategic Cooperation

SHANGHAI, May 15, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK) announced strategic cooperation with Wyeth Nutrition on15 May 2019. Both sides will utilize their strengths in their respective fields for an all...

2019-05-15 15:20 5866

FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, May 15, 2019 /PRNewswire/ -- Not intended for US, Canada and UK-based media  * BAVENCIO is the first anti-PD-L1 in combination with axitinib approved by FDA for first-line treatment of patients with advanced renal cell carcinoma (RCC)  * Phase III study show...

2019-05-15 08:25 3581

Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

BOONE, North Carolina, May 15, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodi...

2019-05-15 07:53 2261

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...

2019-05-15 03:11 2212

Manulife Hong Kong launches tax-deductible ManuWise Deferred Annuity

HONG KONG, May 14, 2019 /PRNewswire/ -- Manulife Hong Kong today launches ManuWise Deferred Annuity (ManuWise), a tax-deductible Qualifying Deferred Annuity Policy (QDAP) certified by the Insurance Authority, to provide customers with more options for retirement planning. In addition to tax bene...

2019-05-14 19:10 9795
1 ... 799800801802803804805 ... 807